Cargando…
GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy
Adjuvant oxaliplatin-based chemotherapy is widely used for stage III colorectal cancer (CRC) after curative surgery. CRC is a molecularly heterogeneous disease, and our current knowledge of therapeutic response-related genetic factors remains limited. N-acetylgalactosaminyltransferase 14 (GALNT14)-r...
Autores principales: | Lin, Wey-Ran, Chiang, Jy-Ming, Liang, Kung-Hao, Lim, Siew-Na, Lai, Ming-Wei, Tsou, Yung-Kuan, Hsieh, Tzu-Yun, Hsu, Chih-Kai, Yeh, Chau-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998711/ https://www.ncbi.nlm.nih.gov/pubmed/27124048 http://dx.doi.org/10.1097/MD.0000000000003487 |
Ejemplares similares
-
GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma
por: Tsou, Yung-Kuan, et al.
Publicado: (2017) -
The GALNT14 Genotype Predicts Postoperative Outcome of Pancreatic Ductal Adenocarcinoma
por: Chiang, Chun-Cheng, et al.
Publicado: (2019) -
GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
por: Lin, Wey-Ran, et al.
Publicado: (2020) -
GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2017) -
Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and GALNT14 Genotype
por: Chen, Tsung-Hsing, et al.
Publicado: (2018)